Alternatives to Conventional Opioids

symposium

My colleague, Richard Rauck, M.D., Pain Fellowship Director at the Wake Forest University of Medicine, and I presented a Continuing Medical Education (CME) symposium at the meeting on atypical opioid options. We discussed the strengths and weakness of three atypical opioids—tramadol, tapentadol, and buprenorphine—that clinicians may consider for the appropriate patients.

Read More

Open Letter to Secretary Tom Price

  Mother Jones reports, “On a listening tour about the opioid epidemic in West Virginia on Tuesday, Health and Human Services Secretary Tom Price stressed the urgency of tackling the staggering overdose problem, saying ‘we’re losing people every single day across the nation, so we don’t have time to wait.’ ” Secretary Tom Price’s View…

Read More

Is Suboxone the New Kleenex®?

Confusion About Suboxone There is an interesting recent article in MEDPAGE TODAY titled “Suboxone Underused, Opioids Overused in Medicine.” To me, that is an oxymoron. As I’ll explain, the title does make sense if you’re trying to communicate to the lay public, but it is an ambiguous and seemingly contradictory statement. Since there’s already way…

Read More

This Is Why an Implant Cannot Stop Heroin Addiction

A recent The Daily Beast article asks the question: Can an implant stop heroin addiction? Heroin Addiction Implant The short answer is that, no, an implant cannot stop heroin addiction. The buprenorphine implant the article cites is only used once someone has already developed an opioid addiction. Therefore, the implant isn’t preventing heroin addiction, it’s…

Read More